Loading…
Outpatient percutaneous coronary intervention: Ready for prime time?
Outpatient practice after percutaneous coronary intervention (PCI) is gaining momentum due to constantly optimizing results. Furthermore, the availability of limited beds to handle the large volume of coronary interventions also promotes outpatient practice. The present report relates the current ex...
Saved in:
Published in: | Canadian journal of cardiology 2007-10, Vol.23 (Suppl B), p.58B-66B |
---|---|
Main Authors: | , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c473t-11d961097cc698527e12b08139ddbbc0cba71f87c184e05919195d6efb5435633 |
---|---|
cites | cdi_FETCH-LOGICAL-c473t-11d961097cc698527e12b08139ddbbc0cba71f87c184e05919195d6efb5435633 |
container_end_page | 66B |
container_issue | Suppl B |
container_start_page | 58B |
container_title | Canadian journal of cardiology |
container_volume | 23 |
creator | Bertrand, Olivier F., MD PhD Larose, Eric, DVM MD De Larochellière, Robert, MD Proulx, Guy, MD Nguyen, Can Manh, MD Déry, Jean-Pierre, MD MSc Gleeton, Onil, MD Barbeau, Gérald, MD Noël, Bernard, MD Rouleau, Jacques, MD Boudreault, Jean-Roch, MD Roy, Louis, MD Rodés-Cabau, Josep, MD |
description | Outpatient practice after percutaneous coronary intervention (PCI) is gaining momentum due to constantly optimizing results. Furthermore, the availability of limited beds to handle the large volume of coronary interventions also promotes outpatient practice. The present report relates the current experience with same-day discharge and defines persisting challenges in promoting accelerated in-hospital turnover. Since the mid-1990s, there have been several reports on same-day discharge following uncomplicated procedures. Overall, the success of outpatient PCI practice is based on a few technological and pharmacological advances. First, the systematic use of stents and potent antiplatelet agents have revolutionized the acute success rates of PCI by virtually eliminating the risks of acute vessel closure within the first 24 h following a successful procedure. Second, the miniaturization of catheter sizes has also simplified access site management, accelerated ambulation time and limited the risks of puncture site bleeding. In this regard, the transradial approach initially described in Canada and later popularized in Europe has transformed the acute care of patients after PCI. Today, however, the practice of transradial PCI still varies largely from country to country. From the literature review, it appears that after a short period of observation (4 h to 6 h), the majority of eligible patients who have undergone uncomplicated coronary stenting can be discharged on the same day. Whereas implementation of same-day discharge to referring centres is simple, home discharge requires the development of structured outpatient programs with dedicated resources to assist the patient and family with short-term logistics, to provide reassurance, to serve as a ‘safety net’ and, lastly, to promote medication compliance and cardiovascular risk factor management. Further studies are required to better define the cost-minimization effects of outpatient PCI practice, as well as patient perception of fast-track PCI. It is proposed that outpatient PCI will likely continue to expand over the next decade. |
doi_str_mv | 10.1016/S0828-282X(07)71012-7 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2794470</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0828282X07710127</els_id><sourcerecordid>68373229</sourcerecordid><originalsourceid>FETCH-LOGICAL-c473t-11d961097cc698527e12b08139ddbbc0cba71f87c184e05919195d6efb5435633</originalsourceid><addsrcrecordid>eNqFkUmP1DAQhS0EYpqBnwDKCcEh4CVJxRxmhIZVGmkkFolbyXEq4CEd99hOS_3vcXdaw3LhYkuuV69efWbsseAvBBfNy8-8lW0pW_ntGYfnkN9kCXfYSmjRlMChvstWt5IT9iDGa84rAdDcZycCtJJ1q1fszdWcNiY5mlKxoWDnZCbycyysD34yYVe4KVHY5rrz06viE5l-Vww-FJvg1lSkfJw_ZPcGM0Z6dLxP2dd3b79cfCgvr95_vHh9WdoKVCqF6HUjuAZrG93WEkjIjrdC6b7vOsttZ0AMLVjRVsRrnVfRdd_Q0NWVqhulTtnZ4ruZuzX1NocKZsR9kpwUvXH4d2VyP_C736IEXVXAs8HTo0HwNzPFhGsXLY3jsjQ2rQIlpc7CehHa4GMMNNwOERz3_PHAH_dwkQMe-CPkvid_JvzddQSeBeeLgDKnraOA0Wb4lnoXyCbsvfvviLN_HOzoJmfN-JN2FK_9HKb8CSgwSuSLyd6Dw8EB1C-quavD</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68373229</pqid></control><display><type>article</type><title>Outpatient percutaneous coronary intervention: Ready for prime time?</title><source>Open Access: PubMed Central</source><source>Elsevier</source><creator>Bertrand, Olivier F., MD PhD ; Larose, Eric, DVM MD ; De Larochellière, Robert, MD ; Proulx, Guy, MD ; Nguyen, Can Manh, MD ; Déry, Jean-Pierre, MD MSc ; Gleeton, Onil, MD ; Barbeau, Gérald, MD ; Noël, Bernard, MD ; Rouleau, Jacques, MD ; Boudreault, Jean-Roch, MD ; Roy, Louis, MD ; Rodés-Cabau, Josep, MD</creator><creatorcontrib>Bertrand, Olivier F., MD PhD ; Larose, Eric, DVM MD ; De Larochellière, Robert, MD ; Proulx, Guy, MD ; Nguyen, Can Manh, MD ; Déry, Jean-Pierre, MD MSc ; Gleeton, Onil, MD ; Barbeau, Gérald, MD ; Noël, Bernard, MD ; Rouleau, Jacques, MD ; Boudreault, Jean-Roch, MD ; Roy, Louis, MD ; Rodés-Cabau, Josep, MD</creatorcontrib><description>Outpatient practice after percutaneous coronary intervention (PCI) is gaining momentum due to constantly optimizing results. Furthermore, the availability of limited beds to handle the large volume of coronary interventions also promotes outpatient practice. The present report relates the current experience with same-day discharge and defines persisting challenges in promoting accelerated in-hospital turnover. Since the mid-1990s, there have been several reports on same-day discharge following uncomplicated procedures. Overall, the success of outpatient PCI practice is based on a few technological and pharmacological advances. First, the systematic use of stents and potent antiplatelet agents have revolutionized the acute success rates of PCI by virtually eliminating the risks of acute vessel closure within the first 24 h following a successful procedure. Second, the miniaturization of catheter sizes has also simplified access site management, accelerated ambulation time and limited the risks of puncture site bleeding. In this regard, the transradial approach initially described in Canada and later popularized in Europe has transformed the acute care of patients after PCI. Today, however, the practice of transradial PCI still varies largely from country to country. From the literature review, it appears that after a short period of observation (4 h to 6 h), the majority of eligible patients who have undergone uncomplicated coronary stenting can be discharged on the same day. Whereas implementation of same-day discharge to referring centres is simple, home discharge requires the development of structured outpatient programs with dedicated resources to assist the patient and family with short-term logistics, to provide reassurance, to serve as a ‘safety net’ and, lastly, to promote medication compliance and cardiovascular risk factor management. Further studies are required to better define the cost-minimization effects of outpatient PCI practice, as well as patient perception of fast-track PCI. It is proposed that outpatient PCI will likely continue to expand over the next decade.</description><identifier>ISSN: 0828-282X</identifier><identifier>EISSN: 1916-7075</identifier><identifier>DOI: 10.1016/S0828-282X(07)71012-7</identifier><identifier>PMID: 17932589</identifier><language>eng</language><publisher>England: Elsevier Inc</publisher><subject>Abciximab ; Abciximab, Discharge, Percutaneous transluminal coronary angioplasty, Radial, Stent ; Ambulatory Care - methods ; Ambulatory Care - standards ; Angioplasty, Balloon, Coronary ; Antibodies, Monoclonal - therapeutic use ; Cardiovascular ; Coronary Artery Disease - drug therapy ; Coronary Artery Disease - therapy ; Coronary Stenosis - drug therapy ; Coronary Stenosis - therapy ; Humans ; Immunoglobulin Fab Fragments - therapeutic use ; Myocardial Infarction - drug therapy ; Myocardial Infarction - therapy ; Patient Discharge ; Platelet Aggregation Inhibitors - therapeutic use ; Quebec ; Stents ; The Quebec Heart Institute ; Time Factors</subject><ispartof>Canadian journal of cardiology, 2007-10, Vol.23 (Suppl B), p.58B-66B</ispartof><rights>Canadian Cardiovascular Society</rights><rights>2007 Canadian Cardiovascular Society</rights><rights>2007, Pulsus Group Inc. All rights reserved</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c473t-11d961097cc698527e12b08139ddbbc0cba71f87c184e05919195d6efb5435633</citedby><cites>FETCH-LOGICAL-c473t-11d961097cc698527e12b08139ddbbc0cba71f87c184e05919195d6efb5435633</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2794470/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2794470/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17932589$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bertrand, Olivier F., MD PhD</creatorcontrib><creatorcontrib>Larose, Eric, DVM MD</creatorcontrib><creatorcontrib>De Larochellière, Robert, MD</creatorcontrib><creatorcontrib>Proulx, Guy, MD</creatorcontrib><creatorcontrib>Nguyen, Can Manh, MD</creatorcontrib><creatorcontrib>Déry, Jean-Pierre, MD MSc</creatorcontrib><creatorcontrib>Gleeton, Onil, MD</creatorcontrib><creatorcontrib>Barbeau, Gérald, MD</creatorcontrib><creatorcontrib>Noël, Bernard, MD</creatorcontrib><creatorcontrib>Rouleau, Jacques, MD</creatorcontrib><creatorcontrib>Boudreault, Jean-Roch, MD</creatorcontrib><creatorcontrib>Roy, Louis, MD</creatorcontrib><creatorcontrib>Rodés-Cabau, Josep, MD</creatorcontrib><title>Outpatient percutaneous coronary intervention: Ready for prime time?</title><title>Canadian journal of cardiology</title><addtitle>Can J Cardiol</addtitle><description>Outpatient practice after percutaneous coronary intervention (PCI) is gaining momentum due to constantly optimizing results. Furthermore, the availability of limited beds to handle the large volume of coronary interventions also promotes outpatient practice. The present report relates the current experience with same-day discharge and defines persisting challenges in promoting accelerated in-hospital turnover. Since the mid-1990s, there have been several reports on same-day discharge following uncomplicated procedures. Overall, the success of outpatient PCI practice is based on a few technological and pharmacological advances. First, the systematic use of stents and potent antiplatelet agents have revolutionized the acute success rates of PCI by virtually eliminating the risks of acute vessel closure within the first 24 h following a successful procedure. Second, the miniaturization of catheter sizes has also simplified access site management, accelerated ambulation time and limited the risks of puncture site bleeding. In this regard, the transradial approach initially described in Canada and later popularized in Europe has transformed the acute care of patients after PCI. Today, however, the practice of transradial PCI still varies largely from country to country. From the literature review, it appears that after a short period of observation (4 h to 6 h), the majority of eligible patients who have undergone uncomplicated coronary stenting can be discharged on the same day. Whereas implementation of same-day discharge to referring centres is simple, home discharge requires the development of structured outpatient programs with dedicated resources to assist the patient and family with short-term logistics, to provide reassurance, to serve as a ‘safety net’ and, lastly, to promote medication compliance and cardiovascular risk factor management. Further studies are required to better define the cost-minimization effects of outpatient PCI practice, as well as patient perception of fast-track PCI. It is proposed that outpatient PCI will likely continue to expand over the next decade.</description><subject>Abciximab</subject><subject>Abciximab, Discharge, Percutaneous transluminal coronary angioplasty, Radial, Stent</subject><subject>Ambulatory Care - methods</subject><subject>Ambulatory Care - standards</subject><subject>Angioplasty, Balloon, Coronary</subject><subject>Antibodies, Monoclonal - therapeutic use</subject><subject>Cardiovascular</subject><subject>Coronary Artery Disease - drug therapy</subject><subject>Coronary Artery Disease - therapy</subject><subject>Coronary Stenosis - drug therapy</subject><subject>Coronary Stenosis - therapy</subject><subject>Humans</subject><subject>Immunoglobulin Fab Fragments - therapeutic use</subject><subject>Myocardial Infarction - drug therapy</subject><subject>Myocardial Infarction - therapy</subject><subject>Patient Discharge</subject><subject>Platelet Aggregation Inhibitors - therapeutic use</subject><subject>Quebec</subject><subject>Stents</subject><subject>The Quebec Heart Institute</subject><subject>Time Factors</subject><issn>0828-282X</issn><issn>1916-7075</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqFkUmP1DAQhS0EYpqBnwDKCcEh4CVJxRxmhIZVGmkkFolbyXEq4CEd99hOS_3vcXdaw3LhYkuuV69efWbsseAvBBfNy8-8lW0pW_ntGYfnkN9kCXfYSmjRlMChvstWt5IT9iDGa84rAdDcZycCtJJ1q1fszdWcNiY5mlKxoWDnZCbycyysD34yYVe4KVHY5rrz06viE5l-Vww-FJvg1lSkfJw_ZPcGM0Z6dLxP2dd3b79cfCgvr95_vHh9WdoKVCqF6HUjuAZrG93WEkjIjrdC6b7vOsttZ0AMLVjRVsRrnVfRdd_Q0NWVqhulTtnZ4ruZuzX1NocKZsR9kpwUvXH4d2VyP_C736IEXVXAs8HTo0HwNzPFhGsXLY3jsjQ2rQIlpc7CehHa4GMMNNwOERz3_PHAH_dwkQMe-CPkvid_JvzddQSeBeeLgDKnraOA0Wb4lnoXyCbsvfvviLN_HOzoJmfN-JN2FK_9HKb8CSgwSuSLyd6Dw8EB1C-quavD</recordid><startdate>20071001</startdate><enddate>20071001</enddate><creator>Bertrand, Olivier F., MD PhD</creator><creator>Larose, Eric, DVM MD</creator><creator>De Larochellière, Robert, MD</creator><creator>Proulx, Guy, MD</creator><creator>Nguyen, Can Manh, MD</creator><creator>Déry, Jean-Pierre, MD MSc</creator><creator>Gleeton, Onil, MD</creator><creator>Barbeau, Gérald, MD</creator><creator>Noël, Bernard, MD</creator><creator>Rouleau, Jacques, MD</creator><creator>Boudreault, Jean-Roch, MD</creator><creator>Roy, Louis, MD</creator><creator>Rodés-Cabau, Josep, MD</creator><general>Elsevier Inc</general><general>Pulsus Group Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20071001</creationdate><title>Outpatient percutaneous coronary intervention: Ready for prime time?</title><author>Bertrand, Olivier F., MD PhD ; Larose, Eric, DVM MD ; De Larochellière, Robert, MD ; Proulx, Guy, MD ; Nguyen, Can Manh, MD ; Déry, Jean-Pierre, MD MSc ; Gleeton, Onil, MD ; Barbeau, Gérald, MD ; Noël, Bernard, MD ; Rouleau, Jacques, MD ; Boudreault, Jean-Roch, MD ; Roy, Louis, MD ; Rodés-Cabau, Josep, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c473t-11d961097cc698527e12b08139ddbbc0cba71f87c184e05919195d6efb5435633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Abciximab</topic><topic>Abciximab, Discharge, Percutaneous transluminal coronary angioplasty, Radial, Stent</topic><topic>Ambulatory Care - methods</topic><topic>Ambulatory Care - standards</topic><topic>Angioplasty, Balloon, Coronary</topic><topic>Antibodies, Monoclonal - therapeutic use</topic><topic>Cardiovascular</topic><topic>Coronary Artery Disease - drug therapy</topic><topic>Coronary Artery Disease - therapy</topic><topic>Coronary Stenosis - drug therapy</topic><topic>Coronary Stenosis - therapy</topic><topic>Humans</topic><topic>Immunoglobulin Fab Fragments - therapeutic use</topic><topic>Myocardial Infarction - drug therapy</topic><topic>Myocardial Infarction - therapy</topic><topic>Patient Discharge</topic><topic>Platelet Aggregation Inhibitors - therapeutic use</topic><topic>Quebec</topic><topic>Stents</topic><topic>The Quebec Heart Institute</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bertrand, Olivier F., MD PhD</creatorcontrib><creatorcontrib>Larose, Eric, DVM MD</creatorcontrib><creatorcontrib>De Larochellière, Robert, MD</creatorcontrib><creatorcontrib>Proulx, Guy, MD</creatorcontrib><creatorcontrib>Nguyen, Can Manh, MD</creatorcontrib><creatorcontrib>Déry, Jean-Pierre, MD MSc</creatorcontrib><creatorcontrib>Gleeton, Onil, MD</creatorcontrib><creatorcontrib>Barbeau, Gérald, MD</creatorcontrib><creatorcontrib>Noël, Bernard, MD</creatorcontrib><creatorcontrib>Rouleau, Jacques, MD</creatorcontrib><creatorcontrib>Boudreault, Jean-Roch, MD</creatorcontrib><creatorcontrib>Roy, Louis, MD</creatorcontrib><creatorcontrib>Rodés-Cabau, Josep, MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Canadian journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bertrand, Olivier F., MD PhD</au><au>Larose, Eric, DVM MD</au><au>De Larochellière, Robert, MD</au><au>Proulx, Guy, MD</au><au>Nguyen, Can Manh, MD</au><au>Déry, Jean-Pierre, MD MSc</au><au>Gleeton, Onil, MD</au><au>Barbeau, Gérald, MD</au><au>Noël, Bernard, MD</au><au>Rouleau, Jacques, MD</au><au>Boudreault, Jean-Roch, MD</au><au>Roy, Louis, MD</au><au>Rodés-Cabau, Josep, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Outpatient percutaneous coronary intervention: Ready for prime time?</atitle><jtitle>Canadian journal of cardiology</jtitle><addtitle>Can J Cardiol</addtitle><date>2007-10-01</date><risdate>2007</risdate><volume>23</volume><issue>Suppl B</issue><spage>58B</spage><epage>66B</epage><pages>58B-66B</pages><issn>0828-282X</issn><eissn>1916-7075</eissn><abstract>Outpatient practice after percutaneous coronary intervention (PCI) is gaining momentum due to constantly optimizing results. Furthermore, the availability of limited beds to handle the large volume of coronary interventions also promotes outpatient practice. The present report relates the current experience with same-day discharge and defines persisting challenges in promoting accelerated in-hospital turnover. Since the mid-1990s, there have been several reports on same-day discharge following uncomplicated procedures. Overall, the success of outpatient PCI practice is based on a few technological and pharmacological advances. First, the systematic use of stents and potent antiplatelet agents have revolutionized the acute success rates of PCI by virtually eliminating the risks of acute vessel closure within the first 24 h following a successful procedure. Second, the miniaturization of catheter sizes has also simplified access site management, accelerated ambulation time and limited the risks of puncture site bleeding. In this regard, the transradial approach initially described in Canada and later popularized in Europe has transformed the acute care of patients after PCI. Today, however, the practice of transradial PCI still varies largely from country to country. From the literature review, it appears that after a short period of observation (4 h to 6 h), the majority of eligible patients who have undergone uncomplicated coronary stenting can be discharged on the same day. Whereas implementation of same-day discharge to referring centres is simple, home discharge requires the development of structured outpatient programs with dedicated resources to assist the patient and family with short-term logistics, to provide reassurance, to serve as a ‘safety net’ and, lastly, to promote medication compliance and cardiovascular risk factor management. Further studies are required to better define the cost-minimization effects of outpatient PCI practice, as well as patient perception of fast-track PCI. It is proposed that outpatient PCI will likely continue to expand over the next decade.</abstract><cop>England</cop><pub>Elsevier Inc</pub><pmid>17932589</pmid><doi>10.1016/S0828-282X(07)71012-7</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0828-282X |
ispartof | Canadian journal of cardiology, 2007-10, Vol.23 (Suppl B), p.58B-66B |
issn | 0828-282X 1916-7075 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2794470 |
source | Open Access: PubMed Central; Elsevier |
subjects | Abciximab Abciximab, Discharge, Percutaneous transluminal coronary angioplasty, Radial, Stent Ambulatory Care - methods Ambulatory Care - standards Angioplasty, Balloon, Coronary Antibodies, Monoclonal - therapeutic use Cardiovascular Coronary Artery Disease - drug therapy Coronary Artery Disease - therapy Coronary Stenosis - drug therapy Coronary Stenosis - therapy Humans Immunoglobulin Fab Fragments - therapeutic use Myocardial Infarction - drug therapy Myocardial Infarction - therapy Patient Discharge Platelet Aggregation Inhibitors - therapeutic use Quebec Stents The Quebec Heart Institute Time Factors |
title | Outpatient percutaneous coronary intervention: Ready for prime time? |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T00%3A32%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Outpatient%20percutaneous%20coronary%20intervention:%20Ready%20for%20prime%20time?&rft.jtitle=Canadian%20journal%20of%20cardiology&rft.au=Bertrand,%20Olivier%20F.,%20MD%20PhD&rft.date=2007-10-01&rft.volume=23&rft.issue=Suppl%20B&rft.spage=58B&rft.epage=66B&rft.pages=58B-66B&rft.issn=0828-282X&rft.eissn=1916-7075&rft_id=info:doi/10.1016/S0828-282X(07)71012-7&rft_dat=%3Cproquest_pubme%3E68373229%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c473t-11d961097cc698527e12b08139ddbbc0cba71f87c184e05919195d6efb5435633%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=68373229&rft_id=info:pmid/17932589&rfr_iscdi=true |